Special Notice Announcing a Period of Performance Extension of the National Cancer Institute’s Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR) contract 75N91019D00024.

Notice Type:

Special Notice Notice Number:

HHS-NIH-NCI-FFRDC-MOSB-0001 Synopsis: Special Notice Announcing a Period of Performance Extension of the National Cancer Institute’s Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR) contract 75N91019D00024.

Date:

January 31, 2024 NOTE: THIS IS A SPECIAL NOTICE. This is NOT a solicitation for proposals, proposal abstracts, or quotations. This notice is pursuant to FAR_5.201(b)(1)(ii).

PURPOSE: The purpose of this notice to inform all interested parties of the Governments intent to extend the ordering period of contract 75N91019D00024 by adding 3 option periods at 12 months each.

ADDITIONAL INFORMATION: Additional information concerning the competitive process for the contract will be announced on https://sam.gov/ as well as at the FNLCR Acquisition Portal: https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/. The information posted to Beta SAM takes precedence over information provided elsewhere and serves as the Government’s official government-wide point of entry (GPE). If you have questions, please email the FNLCR Acquisition Team at: FNLCR_ACQinfo@nih.gov.